271 related articles for article (PubMed ID: 30598328)
1. Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why.
Mol M; Degani G; Coppa C; Baron G; Popolo L; Carini M; Aldini G; Vistoli G; Altomare A
Redox Biol; 2019 May; 23():101083. PubMed ID: 30598328
[TBL] [Abstract][Full Text] [Related]
2. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric approaches for the identification and quantification of reactive carbonyl species protein adducts.
Colzani M; Aldini G; Carini M
J Proteomics; 2013 Oct; 92():28-50. PubMed ID: 23597925
[TBL] [Abstract][Full Text] [Related]
4. Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.
Degani G; Barbiroli A; Magnelli P; Digiovanni S; Altomare A; Aldini G; Popolo L
Glycoconj J; 2019 Feb; 36(1):27-38. PubMed ID: 30612271
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
[TBL] [Abstract][Full Text] [Related]
6. A method to produce fully characterized ubiquitin covalently modified by 4-hydroxy-nonenal, glyoxal, methylglyoxal, and malondialdehyde.
Colzani M; Criscuolo A; Casali G; Carini M; Aldini G
Free Radic Res; 2016; 50(3):328-36. PubMed ID: 26554438
[TBL] [Abstract][Full Text] [Related]
7. Lipoxidation in cardiovascular diseases.
Gianazza E; Brioschi M; Fernandez AM; Banfi C
Redox Biol; 2019 May; 23():101119. PubMed ID: 30833142
[TBL] [Abstract][Full Text] [Related]
8. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
Kang Z; Li H; Li G; Yin D
Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947
[TBL] [Abstract][Full Text] [Related]
9. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms.
Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Mazzitelli G; Cordone S; Pesce C; Pugliese F; Pricci F; Pugliese G
J Pathol; 2009 Jul; 218(3):360-9. PubMed ID: 19334049
[TBL] [Abstract][Full Text] [Related]
10. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).
Baba SP; Hellmann J; Srivastava S; Bhatnagar A
Chem Biol Interact; 2011 May; 191(1-3):357-63. PubMed ID: 21276777
[TBL] [Abstract][Full Text] [Related]
12. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls.
Aldini G; Dalle-Donne I; Facino RM; Milzani A; Carini M
Med Res Rev; 2007 Nov; 27(6):817-68. PubMed ID: 17044003
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin is a binding partner of the human receptor of advanced glycation end products.
Degani G; Altomare A; Digiovanni S; Arosio B; Fritz G; Raucci A; Aldini G; Popolo L
J Biol Chem; 2020 Aug; 295(35):12498-12511. PubMed ID: 32665403
[TBL] [Abstract][Full Text] [Related]
14. Digestibility of Malondialdehyde-Induced Dietary Advanced Lipoxidation End Products and Their Effects on Hepatic Lipid Accumulation in Mice.
Wang Y; Zhang T; Nie L; Zhang Y; Wang J; Liu Q; Dong L; Hu Y; Zhang B; Wang S
J Agric Food Chem; 2023 Jul; 71(27):10403-10416. PubMed ID: 37390008
[TBL] [Abstract][Full Text] [Related]
15. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
16. Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?
Domingues RM; Domingues P; Melo T; Pérez-Sala D; Reis A; Spickett CM
J Proteomics; 2013 Oct; 92():110-31. PubMed ID: 23770299
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel advanced glycation end product derived from lactaldehyde.
Fujimoto S; Murakami Y; Miyake H; Hayase F; Watanabe H
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1136-1145. PubMed ID: 30822216
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases.
Moldogazieva NT; Mokhosoev IM; Mel'nikova TI; Porozov YB; Terentiev AA
Oxid Med Cell Longev; 2019; 2019():3085756. PubMed ID: 31485289
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.
Vistoli G; De Maddis D; Cipak A; Zarkovic N; Carini M; Aldini G
Free Radic Res; 2013 Aug; 47 Suppl 1():3-27. PubMed ID: 23767955
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
